Aims: develop a platform composed of labeled dendrimer nanoparticles and a microfluidic device for real-time monitoring of cancer cells fate. Materials and Methods: The physicochemical and biological characterization of the developed Carboxymethyl-chitosan/poly(amidoamine) (CMCht/PAMAM) dendrimer nanoparticles were performed using TEM, AFM, Zeta Sizer, DSC and cytotoxicity screening. Cancer cell lines derived from different tumor types, including HeLa (Cervical Carcinoma), HCT-116 (Colon Carcinoma) and U87MG (Glioblastoma), were exposed to different concentrations of CMCht/PAMAM dendrimer nanoparticles over a period of 3 days (MTS/DNA). Results: Nanoparticles were successfully modified with an average size of 50 nm. Internalization levels g...
Taking a nanoparticle (NP) from discovery to clinical translation has been slow compared to small mo...
The biological picture of cancer is rapidly advancing from models built from phenomenological descri...
Living therapeutics approaches that exploit mesenchymal stem cells (MSCs) as nanomedicine carriers a...
Statement of Purpose: Circulating tumor cells (CTCs) have been highly studied due to its implication...
Statement of Purpose: Circulating tumor cells (CTCs) have been highly studied due to its implication...
The clinical translation of new cancer theranostic has been delayed by inherent cancerâ s heterogen...
Tese de Doutoramento em Engenharia de Tecidos, Medicina Regenerativa e Células EstaminaisBy 2030, th...
Abstract In vitro and in vivo assessment of safety and efficacy are the essential first steps in dev...
Understanding the mechanism of cancer cell metastasis is crucial for targeted cancer diagnosis and r...
Cancer is considered the disease of the century, which can be easily understood considering its incr...
Using nanoparticles for therapy and imaging holds tremendous promise for the treatment of major dise...
Accepted ManuscriptCancer nanotechnology is a prolific field of research, where nanotools are employ...
The role of microfluidics in liquid biopsy as a more capable solution to address the monitoring of c...
The biological picture of cancer is rapidly advancing from models built from phenomenological descri...
Nanotechnology applications in medicine, termed as nanomedicine, have introduced a number of nanopar...
Taking a nanoparticle (NP) from discovery to clinical translation has been slow compared to small mo...
The biological picture of cancer is rapidly advancing from models built from phenomenological descri...
Living therapeutics approaches that exploit mesenchymal stem cells (MSCs) as nanomedicine carriers a...
Statement of Purpose: Circulating tumor cells (CTCs) have been highly studied due to its implication...
Statement of Purpose: Circulating tumor cells (CTCs) have been highly studied due to its implication...
The clinical translation of new cancer theranostic has been delayed by inherent cancerâ s heterogen...
Tese de Doutoramento em Engenharia de Tecidos, Medicina Regenerativa e Células EstaminaisBy 2030, th...
Abstract In vitro and in vivo assessment of safety and efficacy are the essential first steps in dev...
Understanding the mechanism of cancer cell metastasis is crucial for targeted cancer diagnosis and r...
Cancer is considered the disease of the century, which can be easily understood considering its incr...
Using nanoparticles for therapy and imaging holds tremendous promise for the treatment of major dise...
Accepted ManuscriptCancer nanotechnology is a prolific field of research, where nanotools are employ...
The role of microfluidics in liquid biopsy as a more capable solution to address the monitoring of c...
The biological picture of cancer is rapidly advancing from models built from phenomenological descri...
Nanotechnology applications in medicine, termed as nanomedicine, have introduced a number of nanopar...
Taking a nanoparticle (NP) from discovery to clinical translation has been slow compared to small mo...
The biological picture of cancer is rapidly advancing from models built from phenomenological descri...
Living therapeutics approaches that exploit mesenchymal stem cells (MSCs) as nanomedicine carriers a...